
Gynecologic Oncology Patients' Satisfaction and Symptom Severity During Palliative Chemotherapy
Research on quality and satisfaction with care during palliative chemotherapy in oncology patients has been limited. The objective was to assess the association between patient's satisfaction with care and symptom severity and to evaluate test-retest of a satisfaction survey in this study population.
Published 30 October 2006 
 
 Abstract
 Background
 Research on quality and satisfaction with care during palliative chemotherapy in  oncology patients has been limited. The objective was to assess the association  between patient's satisfaction with care and symptom severity and to evaluate  test-retest of a satisfaction survey in this study population.
 
 Methods
 A prospective cohort of patients with recurrent gynecologic malignancies  receiving chemotherapy were enrolled after a diagnosis of recurrent cancer.  Patients completed the Quality of End-of-Life care and satisfaction with  treatment scale (QUEST) once upon enrollment in an outpatient setting and again  a week later. Patients also completed the Mini-Mental Status Exam, the Hospital  Anxiety/Depression Scale, a symptom severity scale and a demographic survey.  Student's t-test, correlation statistics and percent agreement were used for  analysis.
 
 Results
 Data from 39 patients were analyzed. Mean (SD) quality of care summary score  was 41.95 (2.75) for physicians and 42.23 (5.42) for nurses (maximum score was  45; p = 0.76 for difference in score between providers). Mean (SD) satisfaction  of care summary score was 29.03 (1.92) for physicians and 29.28 (1.70) for  nurses (maximum score was 30; p = 0.49 for difference between providers).  Test-retest for 33 patients who completed both QUEST surveys had high percent  agreement (74–100%), with the exception of the question regarding the provider  arriving late (45 and 53%). There was no correlation between quality and  satisfaction of care and symptom severity. Weakness was the most common symptom  reported. Symptom severity correlated with depression (r = 0.577 p < 0.01).  There was a trend towards a larger proportion of patients reporting pain who had  three or more prior chemotherapy regimens (p = 0.075). Prior number of  chemotherapy regimens or time since diagnosis was not correlated with symptom  severity score. Anxiety and depression were correlated with each other (r =  0.711, p < 0.01). There was no difference in symptom severity score at  enrollment between those patients who have since died (n = 19) versus those who  are still alive.
 
 Conclusion
 The QUEST Survey has test-retest reliability when used as a written  instrument in an outpatient setting. However, there was no correlation between  this measure and symptom severity. Patient evaluation of care may be more  closely related to the interpersonal aspects of the health care provider  relationship than it is to physical symptoms.
References:
Complete article available in 
Health and Quality of Life Outcomes 2006, 4:84 doi:10.1186/1477-7525-4-84
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
















